First Hawaiian Bank’s Esperion Therapeutics ESPR Stock Holding History

First Hawaiian Bank’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-40	Closed	-$2K	–	991
2019 Q1	$2K	Hold	40	–	–	﹤0.01%	1623
2018 Q4	$2K	Hold	40	–	–	﹤0.01%	1721
2018 Q3	$2K	Buy	+40	New	+$1.84K	﹤0.01%	1753

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

First Hawaiian Bank's ESPR Position: Q2 2019 in Review

First Hawaiian Bank sold out of Esperion Therapeutics (ESPR) in Q2 2019, closing a stake of 40 shares — an estimated $2K sold.

First Hawaiian Bank first reported a position in ESPR in Q3 2018 and held it in 3 quarters. The position peaked at $2K in Q1 2019. 167 funds tracked by Wall St. Rank hold ESPR as of Q2 2019.

First Hawaiian Bank reported no remaining Esperion Therapeutics position as of Q2 2019 after selling out during the quarter.
First Hawaiian Bank sold 40 Esperion Therapeutics shares in Q2 2019, an estimated $2K.
First Hawaiian Bank first reported a position in Esperion Therapeutics in Q3 2018 and held it in 3 quarters.
First Hawaiian Bank's Esperion Therapeutics position peaked at $2K in Q1 2019.
167 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.